Long-term outcomes in non-CAH 46,XX DSD
Authors:
Open Access
- 30 April 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1372887
Abstract
Differences/disorders of sex development (DSD) comprise a large group of rare congenital conditions. 46,XX DSD, excluding congenital adrenal hyperplasia (CAH), represent only a small number of these diseases. Due to the rarity of non-CAH 46,XX DSD, data on this sex chromosomal aberration were confined to case reports or case series with small numbers of patients. As the literature is still relatively sparse, medical data on the long-term effects of these pathologies remain scarce. In this review, we aim to provide an overview of current data on the long-term follow-up of patients with non-CAH 46,XX DSD, by covering the following topics: quality of life, gender identity, fertility and sexuality, global health, bone and cardiometabolic effects, cancer risk, and mortality. As non-CAH 46,XX DSD is a very rare condition, we have no accurate data on adult QoL assessment for these patients. Various factors may contribute to a legitimate questioning about their gender identity, which may differ from their sex assigned at birth. A significant proportion of gender dysphoria has been reported in various series of 46,XX DSD patients. However, it is difficult to give an accurate prevalence of gender dysphoria and gender reassignment in non-CAH 46,XX DSD because of the rarity of the data. Whatever the aetiology of non-CAH 46,XX DSD, fertility seems to be impaired. On the other hand, sexuality appears preserved in 46,XX men, whereas it is impaired in women with MRKH syndrome before treatment. Although there is still a paucity of data on general health, bone and cardiometabolic effects, and mortality, it would appear that the 46,XX DSD condition is less severely affected than other DSD conditions. Further structured and continued multi-center follow-up is needed to provide more information on the long-term outcome of this very rare non-CAH 46,XX DSD condition.Keywords
This publication has 49 references indexed in Scilit:
- 46,XX aromatase deficiency: A single-center experience with the varied spectrum and recurrent variants, and a systematic review of hormonal parametersAnnales d'Endocrinologie, 2023
- Sexual function and quality of life after the creation of a neovagina in women with Mayer-Rokitansky-Küster-Hauser syndrome: comparison of vaginal dilation and surgical proceduresFertility and Sterility, 2020
- Surgery is not superior to dilation for the management of vaginal agenesis in Mayer-Rokitansky-Küster-Hauser syndrome: a multicenter comparative observational study in 131 patientsAmerican Journal of Obstetrics and Gynecology, 2018
- Fertility outcome and information on fertility issues in individuals with different forms of disorders of sex development: findings from the dsd-LIFE studyFertility and Sterility, 2017
- SRY-negative 46,XX infertile male with Leydig cell hyperplasia: clinical, cytogenetic, and molecular analysis and review of the literatureFertility and Sterility, 2010
- Gender Change in 46,XY Persons with 5α-Reductase-2 Deficiency and 17β-Hydroxysteroid Dehydrogenase-3 DeficiencyArchives of Sexual Behavior, 2005
- A 46,XX SRY-negative man with complete virilization and infertility as the main anomalyFertility and Sterility, 2005
- Quality-of-life studies in patients with ambiguous genitaliaWorld Journal of Urology, 1999
- Two SRY -negative XX male brothers without genital ambiguityHuman Genetics, 1997
- The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health OrganizationSocial Science & Medicine, 1995